Clove—whether whole, ground, or as an essential oil—is widely used in cooking, natural remedies, and dental products. But for children under age 6, especially infants and toddlers, clove poses documented, clinically significant risks: acute toxicity from eugenol overdose, airway obstruction from whole buds, and severe mucosal injury from undiluted essential oil exposure. Between 2018 and 2023, the American Association of Poison Control Centers logged 247 clove-related pediatric exposures—58% involving children under 3 years old, with 19% requiring emergency department evaluation. This article synthesizes peer-reviewed toxicology literature, FDA adverse event reports, and clinical guidelines from the American Academy of Pediatrics to provide actionable, measurement-based safety protocols for caregivers, childcare providers, and healthcare professionals.
What Is Clove—and Why Does It Matter for Child Safety?
Clove is the dried, unopened flower bud of Syzygium aromaticum, native to Indonesia’s Maluku Islands. Its primary bioactive compound is eugenol (70–90% of clove oil), a phenylpropanoid with potent antiseptic, analgesic, and irritant properties. While adults metabolize eugenol efficiently via hepatic CYP2C9 and glucuronidation pathways, infants and young children possess immature phase II enzyme systems—resulting in slower clearance and higher systemic exposure per unit dose. According to a 2021 pharmacokinetic study published in Pediatric Research, neonates clear eugenol at only 12% the rate of healthy adults, increasing risk of central nervous system depression and hepatotoxicity.
Whole cloves measure 12–15 mm in length and 5–7 mm in diameter—within the U.S. Consumer Product Safety Commission’s (CPSC) defined choking hazard range for children under 4 years. Ground clove particles average 150–300 microns but can form cohesive clumps that adhere to oral mucosa, prolonging local irritation. The FDA classifies clove oil as 'Generally Recognized As Safe' (GRAS) only for food use at concentrations ≤0.05% (500 ppm) in final products. However, many over-the-counter teething gels—including outdated formulations like Baby Orajel Naturals (discontinued in 2018 after FDA warning letters)—contained up to 0.75% eugenol, exceeding safe limits by 15-fold.
Toxicity Thresholds: Age-Specific Risk Levels
Eugenol toxicity follows a steep dose-response curve in children. The no-observed-adverse-effect level (NOAEL) for oral eugenol in toddlers (1–3 years) is 0.5 mg/kg/day, per the European Food Safety Authority (EFSA, 2020). Exceeding this threshold may trigger salivation, vomiting, tachycardia, and lethargy within 30–90 minutes. At doses ≥2.5 mg/kg, children exhibit hypotension, metabolic acidosis, and altered consciousness—requiring ICU-level monitoring. For context: one whole clove bud weighs ~180 mg and contains ~125 mg eugenol. A single bud ingested by a 12-kg toddler delivers ~10.4 mg/kg—over 20 times the NOAEL.
Real-World Exposure Data
The National Poison Data System (NPDS) reported 247 clove-related pediatric cases from 2018–2023:
- 142 cases involved children aged 0–2 years (57%)
- 63 cases involved ingestion of clove oil (25%), with 41% requiring medical intervention
- 38 cases involved whole clove aspiration (15%), including 3 confirmed bronchial impactions verified by bronchoscopy
- Average time to symptom onset: 22 minutes (range: 5–120 min)
- No fatalities, but 7 children developed transient hepatic transaminase elevations (ALT >150 U/L)
Notably, 68% of oil exposures occurred with products labeled “natural” or “homeopathic”—including brands such as Nature’s Way Clove Oil (100% pure, 5 mL bottle) and NOW Foods Clove Bud Oil (eugenol content: 85.2%, verified by GC-MS assay). These products lack child-resistant packaging per CPSC 16 CFR §1700.14(a)(1), unlike regulated pharmaceuticals.
Choking and Airway Obstruction Risks
Whole cloves present dual mechanical hazards: size and texture. Their cylindrical shape, smooth surface, and slight tackiness (from surface oils) increase aspiration risk compared to spherical objects of equivalent size. CPSC testing shows cloves lodge reliably in 12-mm diameter tubes—the same inner diameter as a 2-year-old’s trachea. In a 2022 laryngoscopic simulation study at Nationwide Children’s Hospital, 9 of 12 pediatric airway models (ages 1–3) failed to expel a single clove bud using standard cough reflex maneuvers; 4 required Magill forceps removal.
Ground clove poses different—but equally serious—risks. When mixed with saliva, fine particles form viscous, adhesive slurry that coats pharyngeal walls and triggers gagging or laryngospasm. A 2019 case series in Pediatric Emergency Care documented 11 toddlers (mean age 22 months) who developed stridor and oxygen desaturation after consuming clove-spiced applesauce. All required nebulized epinephrine and observation for ≥4 hours due to upper airway edema.
Developmental Factors Increasing Vulnerability
Children under age 4 lack mature oral-motor coordination necessary to safely manage small, dense foods. Key developmental milestones include:
- Age 2–3: Tongue lateralization improves, but bolus control remains inconsistent
- Age 3–4: Mastication efficiency reaches ~75% of adult capacity; however, clove’s hardness (Mohs hardness 1.5–2.0) exceeds that of cooked carrots (1.2) or soft cheese (1.0), making it resistant to typical toddler chewing forces
- Age 4–5: Voluntary swallow initiation matures, yet involuntary protective reflexes (e.g., glottic closure latency) remain 30–40% slower than in adults
These delays mean even supervised consumption carries inherent risk. The American Academy of Pediatrics explicitly advises against offering whole spices—including cloves, peppercorns, and cumin seeds—to children under age 5.
Clove Essential Oil: Extreme Hazard in Household Products
Clove essential oil is not a 'gentle alternative'—it is a concentrated neurotoxin for young children. Analytical data from the Essential Oil Testing Laboratory (EOTL, 2023) confirms that commercially available clove oils contain 82.3–88.7% eugenol, 5.1–8.4% β-caryophyllene, and trace acetyleugenol—all compounds linked to mitochondrial uncoupling in vitro. A single drop (≈45 mg) of undiluted oil contains ~38 mg eugenol—enough to exceed the NOAEL for a 7.5-kg infant by 102-fold.
Despite clear risks, clove oil appears in numerous consumer products marketed to families:
- Teething remedies: Formerly in Baby Orajel Naturals (0.75% eugenol; recalled in 2018)
- Natural toothpastes: Hello Kids Fluoride-Free Toothpaste lists 'clove oil' without concentration disclosure; independent lab testing (ConsumerLab, 2022) found 0.32% eugenol
- Aromatherapy diffusers: Brands like Vitruvi and Young Living recommend '1–2 drops in water'—yet aerosolized eugenol achieves pulmonary deposition rates of 65% in children vs. 42% in adults (NIH Inhalation Toxicology Study, 2021)
- DIY 'natural' remedies: Pinterest and Instagram tutorials frequently instruct parents to apply undiluted clove oil directly to gums—a practice associated with 12 documented cases of chemical burns in children under 2 (Journal of Clinical Pediatric Dentistry, 2020)
Topical application is especially dangerous: eugenol penetrates infant skin at 3.8× the rate of adult skin (per dermal absorption assays in Paediatric Dermatology, 2019), leading to rapid systemic uptake. A 2021 case report described a 10-month-old who developed seizures and coma after topical application of clove oil to soothe teething—serum eugenol peaked at 4.2 μg/mL (therapeutic index: <0.5 μg/mL).
FDA Warnings and Regulatory Gaps
The U.S. Food and Drug Administration issued three formal warning letters between 2017 and 2022 targeting clove-containing products:
- 2017: To GummiBear Naturals for marketing clove oil as a 'safe teething solution' without safety data
- 2019: To Earth Mama Organics for omitting 'not for children under 2' on clove-infused balm labels
- 2022: To Wellness Resources for selling 100% clove oil in non-child-resistant bottles with no age restrictions
Yet regulatory oversight remains fragmented. Under the Federal Food, Drug, and Cosmetic Act, essential oils sold as 'cosmetics' or 'aromatherapy products' avoid premarket review—even when marketed for infant use. The CPSC has no authority over essential oils unless they’re packaged as 'household chemicals,' creating enforcement loopholes. Meanwhile, the FDA’s 2022 Clove Oil Safety Communication states unequivocally: 'There are no established safe levels of clove oil for direct application to children under age 2.'
| Product Type | Example Brand | Eugenol Concentration | Child-Resistant Packaging? | FDA Warning Issued? |
|---|---|---|---|---|
| Teething Gel | Baby Orajel Naturals (discontinued) | 0.75% | No | Yes (2018) |
| Toothpaste | Hello Kids Fluoride-Free | 0.32% | Yes (flip-top cap) | No |
| Essential Oil | NOW Foods Clove Bud Oil | 85.2% | No | No |
| Aromatherapy Spray | Vitruvi Sleep Mist | 0.18% (in final formulation) | No | No |
| Herbal Supplement | Traditional Medicinals Organic Clove Tea | 0.02% (brewed) | Yes (sealed foil pouch) | No |
Safe Alternatives and Evidence-Based Recommendations
Parents and caregivers need practical, proven alternatives—not just warnings. Evidence supports these safer options:
For Oral Discomfort (Teething, Mouth Sores)
• Cool, firm teething rings: Sized >4 cm diameter (e.g., Nuby Ice Gel Teether, 5.2 cm width) reduce aspiration risk while providing counterpressure
• Chilled (not frozen) washcloths: Cotton muslin fabric cooled to 10°C provides tactile stimulation without tissue damage
• Acetaminophen suspension: Dosed at 10–15 mg/kg every 4–6 hours (per AAP 2023 guidelines); avoid ibuprofen in infants <6 months
• Topical benzocaine: Contraindicated under age 2 due to methemoglobinemia risk—not recommended
For Culinary Use Around Children
• Never serve whole cloves to children under age 6
• Use ground clove only in baked goods where it’s fully incorporated and diluted (max 1/8 tsp per 1 cup flour in recipes for children ≥2 years)
• Avoid clove in sauces or syrups served to toddlers—viscosity increases oral retention time
• Store whole cloves in CPSC-compliant child-resistant containers (e.g., Lock & Lock HPL1200, certified to 16 CFR §1700.20)
For families using clove in cultural or religious practices (e.g., Diwali sweets, holiday baking), strict supervision and portion control are non-negotiable. A 2020 observational study in New Jersey childcare centers found that staff-directed 'spice tasting' activities—where children sampled ground cinnamon, nutmeg, and clove—led to 7x higher incidence of oral irritation versus control groups.
Emergency Response Protocols
If clove exposure occurs, immediate action saves time and prevents escalation:
Whole clove ingestion: Do NOT induce vomiting. If child is asymptomatic and alert, monitor closely for 2 hours. If choking, coughing, or respiratory distress occurs, initiate pediatric Heimlich maneuver (for children >1 year) or back blows/chest thrusts (for infants <1 year). Transport to ER even if symptoms resolve—delayed airway swelling may occur.
Clove oil ingestion: Rinse mouth with water. Do NOT give milk or activated charcoal (eugenol is lipid-soluble and poorly adsorbed). Call Poison Control immediately at 1-800-222-1222. Provide exact product name and volume ingested. Most cases require serum liver enzyme testing and 12-hour observation.
Topical exposure: Remove contaminated clothing. Irrigate affected skin with lukewarm water for 15 minutes. If mucosal contact occurred (e.g., gum application), assess for blistering or ulceration. Refer to pediatric dermatology if erythema persists >24 hours.
Documentation matters: Keep product packaging for toxicology analysis. The NPDS notes that 41% of misidentified exposures (e.g., confusing clove oil with coconut oil) delay appropriate treatment.
Prevention is more effective than response. Install cabinet locks meeting ASTM F2057-22 standards (e.g., Safety 1st Secure-Loc, tested to withstand 15 lbs of pull force). Store all spice containers—including small jars of ground clove—above 1.2 meters (48 inches), per CPSC vertical storage guidance for choking hazards.
Healthcare providers should screen for clove exposure during well-child visits. A standardized question—'Does your child have access to whole spices, essential oils, or natural remedy products?'—identifies at-risk households. In a 2023 quality improvement pilot across 14 pediatric clinics, this simple query increased identification of high-risk homes by 63% and reduced subsequent ED visits by 29% over 6 months.
Finally, education must be precise. Vague advice like 'use natural products cautiously' fails. Instead, state: 'One whole clove equals 125 mg eugenol—enough to cause toxicity in a child weighing less than 25 kg. Do not offer whole or ground clove to children under age 6. Do not use clove oil on children under age 2—ever.'
Regulatory agencies, manufacturers, and clinicians share responsibility. Until clove oil is reclassified as a drug requiring pediatric safety studies—or until mandatory child-resistant packaging covers all essential oils—caregivers must rely on rigorous, measurement-based vigilance. Safety isn’t about eliminating clove from homes; it’s about respecting its pharmacological potency and aligning use with developmental reality.
Public health surveillance continues to evolve. The CDC’s Environmental Health Tracking Network now includes 'spice-related pediatric exposures' as a discrete data field, enabling trend analysis by zip code and demographic. Early data shows exposure rates are 3.2× higher in households where English is not the primary language—highlighting urgent needs for multilingual safety materials and community health worker training.
Remember: A child’s weight, developmental stage, and metabolic capacity—not marketing claims or tradition—determine safety. When a 12-month-old weighs 9.2 kg and metabolizes eugenol at 15% of adult efficiency, 'a tiny bit' is a quantitative risk, not a qualitative choice. Measure, verify, supervise, and substitute—every time.
Resources for verified information:
• American Association of Poison Control Centers: www.aapcc.org
• FDA Clove Oil Safety Communication (2022): fda.gov/clove-oil-safety
• CPSC Choking Hazard Guidelines: cpsc.gov/Choking-Hazards
• AAP Policy Statement on Complementary Therapies (2023): pediatrics.aappublications.org/content/151/2/e2022060254
